Internal Medicine, Endocrinology, Diabetes, & Metabolism · Staten Island, NY
NPI
1487649885
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1460 Victory Blvd
Staten Island, NY, 10301
Phone (718) 442-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
2,273 services
Medicare patients, 2024
857
Average age 72
Drug cost, 2024
$8.4M
13,475 prescriptions
Company payments, 2025
$7,631
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahed Quyyumi was code 99214 (office e&m - established), 827 times for 511 patients. In total Shahed Quyyumi billed 2,273 services in 16 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 827 | 511 | $94.64 | $78K |
| 82962 Clinical Chemistry | Office | 656 | 430 | $3.19 | $2,093 |
| 76536 Ultrasound - Nonspecific | Office | 302 | 290 | $86.50 | $26K |
| 83036 Blood Count | Office | 186 | 159 | $9.52 | $1,771 |
| 99204 Office E&M - New | Office | 100 | 100 | $126.51 | $13K |
| 99213 Office E&M - Established | Office | 50 | 47 | $70.86 | $3,543 |
| 99214 Office E&M - Established | Facility | 41 | 38 | $81.17 | $3,328 |
| 90662 Vaccine Product | Office | 24 | 24 | $81.82 | $1,964 |
| G0008 Administration of influenza virus vaccine | Office | 24 | 24 | $37.09 | $890 |
| 96372 Injection Administration | Office | 20 | 17 | $11.68 | $234 |
By year: 2022 $127K for 2,103 services; 2023 $134K for 2,173 services; 2024 $133K for 2,273 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 656 | 430 | $3.19 | $2,093 |
| 83036 Blood Count | 186 | 159 | $9.52 | $1,771 |
Medicare prescription drug claims, 2024
In 2024, the drug Shahed Quyyumi prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,709 prescriptions and refills. In total Shahed Quyyumi wrote 13,475 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,709 | 2,359 | 299 | $2.5M |
| Pioglitazone Hcl Generic | 1,360 | 3,591 | 424 | $18K |
| Ozempic Semaglutide | 853 | 1,466 | 199 | $1.4M |
| Atorvastatin Calcium Generic | 726 | 2,005 | 239 | $8,358 |
| Levothyroxine Sodium Generic | 678 | 1,913 | 213 | $7,906 |
| Ezetimibe Generic | 514 | 1,361 | 168 | $14K |
| Metformin Hcl Generic | 499 | 1,394 | 181 | $8,467 |
| Tresiba Flextouch U-200 Insulin Degludec | 458 | 981 | 134 | $527K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 432 | 961 | 136 | $444K |
| Trulicity Dulaglutide | 349 | 561 | 90 | $540K |
| Jardiance Empagliflozin | 282 | 566 | 85 | $323K |
| Farxiga Dapagliflozin Propanediol | 240 | 540 | 71 | $292K |
| Rosuvastatin Calcium Generic | 223 | 624 | 79 | $4,364 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 215 | 571 | 103 | $13K |
| Metformin Hcl Er Metformin Hcl | 211 | 546 | 83 | $2,738 |
Brand drugs: 6,463 claims; generic drugs: 6,258 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahed Quyyumi $7,631 ($7,631 in general payments such as food, travel and fees) from 31 companies. The largest payer was Corcept Therapeutics with $2,893.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 4 | $2,893 |
| Amgen Inc. AMGN | 13 | $676 |
| Novo Nordisk Inc NVO | 22 | $461 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $424 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $330 |
| Lilly USA, LLC LLY | 17 | $281 |
| Abbott Laboratories ABT | 6 | $269 |
| Ascendis Pharma Endocrinology Inc ASND | 7 | $243 |
| Mannkind Corporation MNKD | 9 | $202 |
| Insulet Corporation PODD | 9 | $201 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.